Leflunomide in combination therapy for rheumatoid arthritis

Drug Saf. 2010 Jun 1;33(6):523-6. doi: 10.2165/11532390-000000000-00000.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antirheumatic Agents / administration & dosage*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Australia / epidemiology
  • Drug Therapy, Combination / adverse effects*
  • Humans
  • Infections / epidemiology
  • Isoxazoles / administration & dosage*
  • Isoxazoles / adverse effects*
  • Leflunomide
  • Methotrexate / adverse effects
  • New Zealand / epidemiology
  • Pancytopenia / chemically induced
  • Pneumonia / chemically induced

Substances

  • Antirheumatic Agents
  • Isoxazoles
  • Leflunomide
  • Methotrexate